Albemarle heads into its May 6 earnings release with short sellers at their most aggressive in months — and options traders adding to the cautious tone.
Short interest has climbed sharply, from roughly 7% of the free float in early April to 9.3% by April 30. That's a 32% increase in one month, with the pace accelerating over the final week. The move is notable because it breaks a multi-week plateau: shorts held steady through mid-April, then stepped up consistently from April 23 onwards. The ORTEX short score has followed, rising from 46.3 to 50.2 in ten days. Despite all that new positioning, the borrow market remains easy — availability is wide, cost to borrow is just 0.42%, and even after a 53% rise over the month, borrowing ALB is essentially free. That low friction is keeping the door open for further short builds ahead of the print.
Options positioning reinforces the defensive lean. The put/call ratio is running above its recent average at 1.20, roughly 1.4 standard deviations above the 20-day mean of 1.13. It's well short of the 52-week high of 1.79, so this isn't panic hedging — but the consistent drift higher in PCR through April points to growing demand for downside protection. The stock itself has recovered well, up 8% over the past month to close around $193.88, with a 3% gain on the week. The short build is happening into price strength, not after a collapse.
The analyst community has moved in a clear direction since late April. RBC Capital, BofA, Truist, and UBS all raised price targets in the past two weeks, with most landing in the $225–$245 range against a mean target near $197. The gap between where the Street sits and where those leading-edge targets cluster suggests expectations have been moving faster than consensus. The lone dissenter was Baird, which cut its rating to Neutral on April 17 while holding its target. Bulls focus on Albemarle's integrated lithium position and the structural demand from EVs and grid storage. Bears point to lithium price volatility, limited visibility on regulatory support, and the risk that competitors add capacity faster than demand grows.
Past earnings have not been kind to longs — the last reported quarter saw the stock fall more than 5% on the day and roughly 4% over the following five sessions. The May 6 print will test whether the recent analyst target upgrades reflect genuine earnings momentum, or whether they're running ahead of a lithium market that hasn't yet delivered the pricing recovery those targets imply.
See the live data behind this article on ORTEX.
Open ALB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
